Biophytis (EPA:ALBPS) | WebDisclosure

Basculer en Français

9811	Companies
196813	Keywords
127837	Articles
104643	Press releases

Home
Companies
Biophytis

PRESS RELEASE

published on 12/29/2023 at 07:00, 2 years 1 month ago

Biophytis annonce le tirage de la quatrième tranche d'ORNANE dans le cadre du contrat Atlas 2021
Biophytis annonce le tirage de la quatrième tranche d'ORNANE dans le cadre du contrat Atlas 2021. La société de biotechnologie au stade clinique spécialisée dans le développement de traitements qui visent à ralentir les processus dégénératifs liés au vieillissement va émettre 80 ORNANE pour un montant de 2 millions d’euros, avec une option complémentaire de 80 ORNANE pour un montant de 2 millions d’euros le 15 février 2024

Biophytis ORNANE Atlas 2021 Fonds D'investissement Obligations Remboursables
PRESS RELEASE

published on 12/29/2023 at 07:00, 2 years 1 month ago

Biophytis announces the drawing of the fourth tranche of ORNANE under the 2021 Atlas Contract
Biophytis, a clinical-stage biotechnology company focused on developing therapeutics for age-related diseases, has announced the drawing of the fourth tranche of its convertible bond agreement with Atlas, a specialized investment fund based in New York. This tranche consists of 80 Bonds Redeemable in Cash and New and Existing Shares (ORNANE) with a total value of €4 million. The ORNANE have a 24-month maturity period and do not bear interest. Holders have the option
ARTICLE

published on 12/11/2023 at 07:49, 2 years 1 month ago

Biophytis présente son calendrier de conférences internationales pour le premier trimestre 2024
Biophytis SA confirme sa présence dans des conférences clés du secteur de la santé, visant à renforcer ses relations et à présenter ses avancées

Biophytis Biotechnologie Sarconeos (BIO101) Conférences Traitements Anti-vieillissement
ARTICLE

published on 12/04/2023 at 08:00, 2 years 2 months ago

Biophytis et l'Université de Liège s'associent pour combattre l'insuffisance respiratoire virale
Biophytis annonce un partenariat avec l'Université de Liège pour étudier Sarconeos (BIO101) dans le traitement de pathologies respiratoires

Biophytis Université De Liège Insuffisance Respiratoire Recherche Préclinique Médicament Sarconeos
PRESS RELEASE

published on 11/27/2023 at 07:00, 2 years 2 months ago

Biophytis nomme Yann Meunier et Bernard Lévy à son comité scientifique
PRESS RELEASE

published on 11/20/2023 at 07:00, 2 years 2 months ago

Biophytis annonce le succès de son augmentation de capital avec maintien du droit préférentiel de souscription pour un montant d’environ 1,96 M€
PRESS RELEASE

published on 11/17/2023 at 23:00, 2 years 2 months ago

Biophytis reçoit une notification du Nasdaq
PRESS RELEASE

published on 11/06/2023 at 07:00, 2 years 2 months ago

Biophytis to attend BIO-Europe in Munich
PRESS RELEASE

published on 11/06/2023 at 07:00, 2 years 2 months ago

Biophytis participe à BIO-Europe à Munich
PRESS RELEASE

published on 10/30/2023 at 06:00, 2 years 3 months ago

Biophytis et Innovation Solutions Pharma signent un partenariat en vue d’accélérer l’accès au marché de Sarconeos (BIO101) au Brésil

Accesswire

Published on 02/05/2026 at 15:45, 13 minutes ago

American Critical Minerals Recaps a Highly Successful 6 Months and Files Amended and Restated Technical Report
Published on 02/05/2026 at 15:10, 48 minutes ago

Electric Metals (USA) Limited Announces Change of Auditor
Published on 02/05/2026 at 14:50, 1 hour 8 minutes ago

High Tide Resources Announces Non-Brokered Private Placements
Published on 02/05/2026 at 14:30, 1 hour 28 minutes ago

Electrovaya Announces Date for Q1-2026 Financial Results & Conference Call
Published on 02/05/2026 at 14:30, 1 hour 28 minutes ago

Innodata to Report Fourth Quarter and Fiscal Year 2025 Results

View all ACCESSWIRE

EQS Group

Published on 02/05/2026 at 15:40, 18 minutes ago

BIKE24 exceeds revenue and earnings forecast for fiscal year 2025 – strong growth in the fourth quarter
Published on 02/05/2026 at 15:34, 24 minutes ago

EQS-Adhoc: Bike24 Holding AG: Preliminary sales and earnings exceed the previous forecast range for the 2025 financial year
Published on 02/05/2026 at 15:15, 43 minutes ago

FIS SUCCESSFULLY COMPLETES €770 MILLION BOND ISSUANCE
Published on 02/05/2026 at 15:13, 45 minutes ago

Form 8.3 - The Vanguard Group, Inc.: JTC plc
Published on 02/05/2026 at 15:12, 45 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Glencore plc

Les Echos

Published on 02/05/2026 at 11:30, 4 hours 28 minutes ago

Déclaration nombre d'actions et droits de vote - 05.02.2026
Published on 02/05/2026 at 11:30, 4 hours 28 minutes ago

Disclosure of shares outstanding and voting rights - 05.02.2026
Published on 02/04/2026 at 18:04, 21 hours 54 minutes ago

Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 21 hours 54 minutes ago

Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 22 hours 13 minutes ago

Information concerning the total number of voting rights and shares 2026 01 31

View all LES ECHOS COMFI WIRE